198 related articles for article (PubMed ID: 27558082)
1. Durable clinical remission induced by romidepsin for chemotherapy-refractory peripheral T-cell lymphoma with central nervous system involvement.
Chan KL; van der Weyden C; Khoo C; Lade S; Blombery P; Westerman D; Khot A; Melo B; Johnstone RW; Prince HM; Dickinson M
Leuk Lymphoma; 2017 Apr; 58(4):996-998. PubMed ID: 27558082
[No Abstract] [Full Text] [Related]
2. Combination of romidepsin with cyclophosphamide, doxorubicin, vincristine, and prednisone in previously untreated patients with peripheral T-cell lymphoma: a non-randomised, phase 1b/2 study.
Dupuis J; Morschhauser F; Ghesquières H; Tilly H; Casasnovas O; Thieblemont C; Ribrag V; Bossard C; Le Bras F; Bachy E; Hivert B; Nicolas-Virelizier E; Jardin F; Bastie JN; Amorim S; Lazarovici J; Martin A; Coiffier B
Lancet Haematol; 2015 Apr; 2(4):e160-5. PubMed ID: 26687958
[TBL] [Abstract][Full Text] [Related]
3. [Diagnosis and treatment of peripheral T-cell lymphoma].
Suzumiya J; Moriyama I; Kawakami K
Nihon Rinsho; 2012 Apr; 70 Suppl 2():519-24. PubMed ID: 23134009
[No Abstract] [Full Text] [Related]
4. Central nervous system relapse in peripheral T-cell lymphomas: a Swedish Lymphoma Registry study.
Ellin F; Landström J; Jerkeman M; Relander T
Blood; 2015 Jul; 126(1):36-41. PubMed ID: 25957393
[TBL] [Abstract][Full Text] [Related]
5. Long-term remission in a patient with hepatosplenic gammadelta T cell lymphoma treated with bortezomib and high-dose CHOP-like chemotherapy followed by autologous peripheral stem cell transplantation.
Otrock ZK; Hatoum HA; Salem ZM; Tawil A; Mahfouz RA; Zaatari GS; Bazarbachi A
Ann Hematol; 2008 Dec; 87(12):1023-4. PubMed ID: 18587577
[No Abstract] [Full Text] [Related]
6. First-line therapy of peripheral T-cell lymphoma: extension and long-term follow-up of a study investigating the role of autologous stem cell transplantation.
Wilhelm M; Smetak M; Reimer P; Geissinger E; Ruediger T; Metzner B; Schmitz N; Engert A; Schaefer-Eckart K; Birkmann J
Blood Cancer J; 2016 Jul; 6(7):e452. PubMed ID: 27471868
[TBL] [Abstract][Full Text] [Related]
7. Autologous stem cell transplantation remains beneficial for patients relapsing after R-CHOP chemotherapy and who respond to salvage chemotherapy.
Moore S; Peggs K; Thomson K; Lowry L; Ljubic A; Goldstone AH; Linch DC; Ardeshna KM
Br J Haematol; 2012 Jan; 156(1):142-3. PubMed ID: 21848889
[No Abstract] [Full Text] [Related]
8. Point: The Role of Stem Cell Transplantation in Mantle Cell Lymphoma: Where It Fits in the New Paradigm.
Goy A
Oncology (Williston Park); 2016 Dec; 30(12):1055-8, 1060. PubMed ID: 27987196
[No Abstract] [Full Text] [Related]
9. Managing early failures with R-CHOP in patients with diffuse large B-cell lymphoma.
Camus V; Tilly H
Expert Rev Hematol; 2017 Dec; 10(12):1047-1055. PubMed ID: 27791447
[TBL] [Abstract][Full Text] [Related]
10. Dose-Adjusted EPOCH-R and Mid-Cycle High Dose Methotrexate for Patients with Systemic Lymphoma and secondary CNS Involvement.
Chihara D; Fowler NH; Oki Y; Fanale MA; Fayad LE; Westin JR; Hagemeister FB
Br J Haematol; 2017 Dec; 179(5):851-854. PubMed ID: 27502933
[No Abstract] [Full Text] [Related]
11. Extranodal lymphoma: a reappraisal.
Zucca E
Ann Oncol; 2008 Jun; 19 Suppl 4():iv77-80. PubMed ID: 18519412
[No Abstract] [Full Text] [Related]
12. Composite diffuse large B-cell lymphoma and CD20-positive peripheral T-cell lymphoma.
Yamazaki S; Fujioka Y; Nakamura F; Ota S; Shinozaki A; Yamamoto G; Kamikubo Y; Nannya Y; Ichikawa M; Fukayama M; Kurokawa M
Pathol Int; 2011 Nov; 61(11):662-6. PubMed ID: 22029677
[TBL] [Abstract][Full Text] [Related]
13. Barriers to enrollment of patients with recurrent diffuse large B-cell lymphoma onto clinical trials.
Marton A; Kezouh A; Petrogiannis-Haliotis T; Assouline S
Leuk Lymphoma; 2015; 56(9):2747-9. PubMed ID: 25651426
[No Abstract] [Full Text] [Related]
14. Therapeutic options in relapsed or refractory peripheral T-cell lymphoma.
Coiffier B; Federico M; Caballero D; Dearden C; Morschhauser F; Jäger U; Trümper L; Zucca E; Gomes da Silva M; Pettengell R; Weidmann E; d'Amore F; Tilly H; Zinzani PL
Cancer Treat Rev; 2014 Oct; 40(9):1080-8. PubMed ID: 25199959
[TBL] [Abstract][Full Text] [Related]
15. Isolated central nervous system relapse in a patient with systemic diffuse large B-cell lymphoma: Diagnostic and treatment challenges.
Das P; Dubashi B; Joseph D; Jain A
Indian J Cancer; 2014; 51(4):468-9. PubMed ID: 26842164
[No Abstract] [Full Text] [Related]
16. Extranodal marginal zone B-cell lymphoma most probably of MALT type appearing in CNS as parasagittal extracerebral tumor.
Marinković M; Slavik E; Janković S; Cemerikic V; Radulović D
J Neurosurg Sci; 2006 Mar; 50(1):9-12. PubMed ID: 16557194
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxic T-cell lymphoma presenting as secondary myelofibrosis with high levels of PDGF and TGF-beta.
Abe Y; Ohshima K; Shiratsuchi M; Honda K; Nishimura J; Nawata H; Muta K
Eur J Haematol; 2001 Mar; 66(3):210-2. PubMed ID: 11350491
[No Abstract] [Full Text] [Related]
18. Complete remission of primary cutaneous intravascular large B-cell lymphoma with R-CHOP followed by rituximab monotherapy.
Pantelaki I; Tigges C; Nußbaum T; Oellig F; Wieland U; Kreuter A
Dermatol Ther; 2017 Jul; 30(4):. PubMed ID: 28508527
[No Abstract] [Full Text] [Related]
19. Duvelisib as bridge to allotransplantation in refractory peripheral T-cell lymphoma with T-follicular helper phenotype: case report.
Lolli G; Casadei B; Pellegrini C; Argnani L; Cocito F; Zinzani PL
Tumori; 2021 Dec; 107(6):NP105-NP107. PubMed ID: 34167407
[TBL] [Abstract][Full Text] [Related]
20. The first case report of composite bone marrow involvement by simultaneously developed peripheral T-cell lymphoma, not otherwise specified, and diffuse large B-cell lymphoma.
Kim HK; Park CJ; Jang S; Cho YU; Park SH; Choi J; Park CS; Huh J; Chung YH; Lee JH
Ann Lab Med; 2015 Jan; 35(1):152-4. PubMed ID: 25553299
[No Abstract] [Full Text] [Related]
[Next] [New Search]
